Featuring perspectives from Ms Kathryn M Lyle, Dr Ritu Salani, Ms Jaclyn Shaver and Dr Brian M Slomovitz, including the following topics:

• Introduction: Overview of Endometrial Cancer (0:00)
• First-Line Therapy for Advanced or Recurrent Endometrial Cancer (11:01)
• Role of Lenvatinib/Pembrolizumab in the Management of Progressive Advanced Endometrial Cancer (39:09)
• Novel Investigational Strategies for Newly Diagnosed Advanced Endometrial Cancer (1:00:15)
• Incidence and Management of HER2-Positive Endometrial Cancer (1:17:52)

NCPD information and select publications

Featuring perspectives from Dr Stephen M Ansell and Dr Brian T Hill, including the following topics:

• Introduction: Bispecific Antibodies in Community Practice (0:00)
• Diffuse Large B-Cell Lymphoma (7:06)
• CD19, CD20 or Both? AZD0486 Bispecific Antibody (29:15)
• Mantle Cell Lymphoma (32:36)
• Follicular Lymphoma (48:08)
• CAR T-Cell Therapy for Marginal Zone Lymphoma (57:17)

CME information and select publications

Year in Review: Clinical Investigator Perspectives on the Most Relevant New Datasets and Advances in Non-Hodgkin Lymphoma | Faculty Presentation 2: Other Available and Emerging Novel Therapies for NHL — Stephen M Ansell, MD, PhD

CME information and select publications

Year in Review: Clinical Investigator Perspectives on the Most Relevant New Datasets and Advances in Non-Hodgkin Lymphoma | Faculty Presentation 1: Current Role of Chimeric Antigen Receptor (CAR) T-Cell Therapy and Bispecific Antibodies in Various Non-Hodgkin Lymphoma (NHL) Subtypes — Brian T Hill, MD, PhD

CME information and select publications

Featuring perspectives from Dr Ian E Krop and Dr Sara M Tolaney, including the following topics:

• Introduction: Adjuvant CDK4/6 Inhibition (0:00)
• HER2-Positive Disease (11:13)
• PARP Inhibition (27:34)
• Antibody-Drug Conjugates (34:12)
• Up-Front Treatment of HR-Positive Metastatic Disease (46:28)

CME information and select publications

Featuring perspectives from Dr Daniel George, Dr Leonard G Gomella and Dr Evan Y Yu, moderated by Dr George, including the following topics:

• Introduction (0:00)
• Current Treatment Landscape for Metastatic Hormone-Sensitive Prostate Cancer (mHSPC) — Dr Gomella (3:42)
• Clinical Implications of and Appropriate Strategies to Identify PTEN Deficiency in Prostate Cancer — Dr Yu (35:37)
• Emerging Role of AKT Inhibition for mHSPC — Dr George (1:06:18)

CME information and select publications

Featuring perspectives from Dr Prithviraj Bose and Dr Andrew T Kuykendall, including the following topics:

• Systemic Mastocytosis — Dr Bose (0:00)
• Myelofibrosis — Dr Kuykendall (24:46)

CME information and select publications

Featuring perspectives from Dr Thomas A Abrams and Dr Ahmed Omar Kaseb, including the following topics:

• Current Treatment for Advanced Hepatocellular Carcinoma (HCC) — Dr Abrams (0:00)
• Promising Novel Approaches to HCC Management — Dr Kaseb (33:46)

CME information and select publications